Prokidney (PROK) Current Assets (2021 - 2026)
Prokidney's (PROK) quarterly Current Assets came in at $189.8 million in Q2 2026, down 41.51% year-over-year from $324.4 million in Q2 2025, and down 19.21% quarter-over-quarter from $234.9 million in Q1 2026.
Analysis
Prokidney (PROK) Current Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Current Assets for 6 consecutive years, with $189.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets fell 41.51% year-over-year to $189.8 million in Q2 2026; TTM through Jun 2026 was $189.8 million, a 41.51% decrease from a year earlier, with the FY2025 full-year figure at $280.7 million, down 29.1% from the prior year.
- Current Assets was $189.8 million for Q2 2026 at Prokidney, down from $234.9 million in the prior quarter.
- Over five years, Current Assets peaked at $519.4 million in Q3 2022 and troughed at $594977.0 in Q1 2022.
- A 5-year average of $336.6 million and a median of $366.9 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 80599.42% in 2023 and sank 41.51% in 2026, its largest moves.
- Over 5 years, Current Assets stood at $504.7 million in 2022, then retreated by 25.87% to $374.1 million in 2023, then climbed by 5.81% to $395.9 million in 2024, then dropped by 29.1% to $280.7 million in 2025, then plunged by 32.39% to $189.8 million in 2026.
- The last three Current Assets figures came in at $189.8 million (Q2 2026), $234.9 million (Q1 2026), and $280.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.06 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.37 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 464.26 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.23 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 834.27 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.18 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 134.38 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 2.22 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 264.73 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 189.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.77 Mn |
| Mar 31, 2026 | 234.90 Mn |
| Dec 31, 2025 | 280.68 Mn |
| Sep 30, 2025 | 299.99 Mn |
| Jun 30, 2025 | 324.44 Mn |
| Mar 31, 2025 | 359.66 Mn |
| Dec 31, 2024 | 395.88 Mn |
| Sep 30, 2024 | 430.23 Mn |
| Jun 30, 2024 | 450.26 Mn |
| Mar 31, 2024 | 340.16 Mn |
| Dec 31, 2023 | 374.15 Mn |
| Sep 30, 2023 | 406.42 Mn |
| Jun 30, 2023 | 466.43 Mn |
| Mar 31, 2023 | 480.14 Mn |
| Dec 31, 2022 | 504.72 Mn |
| Sep 30, 2022 | 519.37 Mn |
| Jun 30, 2022 | 632,296.00 |
| Mar 31, 2022 | 594,977.00 |
| Dec 31, 2021 | 27.27 Mn |
| Sep 30, 2021 | 1.44 Mn |